Pfizer
Utility Patent Applications
Last updated:
List of all Pfizer patents 264 in total
| Status | Patent |
|---|---|
Application | Utility: Combinations For Treatment Of NASH/NAFLD And Related Diseases Filling date: 13 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF Filling date: 13 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS WITH RENAL IMPAIRMENT OR CHRONIC KIDNEY DISEASE Filling date: 13 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: ANTI-GDF15 ANTIBODIES, COMPOSITIONS AND METHODS OF USE Filling date: 13 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: TYROSINE PROTOTROPHY Filling date: 13 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: Therapeutic Polymeric Nanoparticles Comprising Lipids and Methods of Making and Using Same Filling date: 13 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: COMBINATION OF AN ANTI-PD-L1 ANTIBODY AND A DNA-PK INHIBITOR FOR THE TREATMENT OF CANCER Filling date: 13 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: RORC2 INHIBITORS AND METHODS OF USE THEREOF Filling date: 13 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: METHODS OF TREATING OR REDUCING THE RISK OF CARDIOVASCULAR EVENTS AND RELTED DISEASES USING SGLT-2 INHIBITORS Filling date: 13 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: AMINOPYRIMIDINYL COMPOUNDS Filling date: 13 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: CYCLIC SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE DERIVATIVES Filling date: 13 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: COMPOSITION COMPRISING AVELUMAB Filling date: 13 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING Filling date: 13 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: AQUEOUS ANTI-PD-L1 ANTIBODY FORMULATION Filling date: 13 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: ANTIBODIES SPECIFIC FOR GUCY2C AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 9 Jan 2020 |
Application | Utility: SULFONYL AMIDE DERIVATIVES FOR THE TREATMENT OF ABNORMAL CELL GROWTH Filling date: 13 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: NOVEL 3-AMINO-PYRROLO[3,4-C]PYRAZOLE-5(1H, 4H,6H) CARBALDEHYDE DERIVATIVES Filling date: 13 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: SALTS AND POLYMORPHS OF 8-FLUORO-2-{4-[(METHYLAMINO)METHYL]PHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINO[- 5,4,3-CD]INDOL-6-ONE Filling date: 13 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: MULTI-SITE SPECIFIC INTEGRATION CELLS FOR DIFFICULT TO EXPRESS PROTEINS Filling date: 13 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: Methyl- and Trifluromethyl-Substituted Pyrrolopyridine Modulators of RORC2 and Methods of Use Thereof Filling date: 13 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: 1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AND 1,1,1-TRIFLUORO-4-HYDROXYBUTAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: GLP-1 Receptor Agonists and Uses Thereof Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: GLP-1 Receptor Agonists and Uses Thereof Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: CRYSTALLINE FORMS OF 1-((2R,4R)-2-(1H-BENZO[D]IMIDAZOL-2-YL)-1-METHYLPIPERIDIN-4-YL)-3-(4-CYAN- OPHENYL)UREA MALEATE Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: GLP-1 Receptor Agonists and Uses Thereof Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: ANTIBODIES SPECIFIC FOR CD3 AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: LARGE SCALE PRODUCTION PROCESS FOR CAPPED AND UN-CAPPED ANTIBODY CYSTEINES AND THEIR USE IN THERAPEUTIC PROTEIN CONJUGATION Filling date: 13 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS Filling date: 13 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: CRYSTALLINE FORM OF LORLATINIB FREE BASE Filling date: 13 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: PURIFICATION OF ANTIBODY DRUG CONJUGATES USING A SODIUM PHOSPHATE GRADIENT Filling date: 13 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: CALICHEAMICIN DERATIVES AND ANTIBODY DRUG CONJUGATES THEREOF Filling date: 13 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: Immunogenic Compositions for Use in Pneumococcal Vaccines Filling date: 13 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: GLYCOCONJUGATION PROCESS Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: TUMOR NECROSIS FACTOR-LIKE LIGAND 1A SPECIFIC ANTIBODIES AND COMPOSITIONS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: CYCLIN DEPENDENT KINASE INHIBITORS Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: CANCER TREATMENT Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: Dosing Regimen of Avelumab for the Treatment of Cancer Filling date: 13 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: IMIDAZOPYRIDAZINE COMPOUNDS Filling date: 13 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: SUBSTITUTED-6,8-DIOXABICYCLO[3.2.1]OCTANE-2,3-DIOL COMPOUNDS AS TARGETING AGENTS OF ASGPR Filling date: 13 Sep 2025 Issue date: 24 Oct 2019 |
Application | Utility: Stable Liquid Antibody Formulation Filling date: 13 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: NOVEL PYRIMIDINE CARBOXAMIDES AS INHIBITORS OF VANIN-1 ENZYME Filling date: 13 Sep 2025 Issue date: 17 Oct 2019 |
Application | Utility: 6,7-DIHYDRO-5H-PYRAZOLO[5,1-B][1,3]OXAZINE-2-CARBOXAMIDE COMPOUNDS Filling date: 13 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: Antibodies to MAdCAM Filling date: 13 Sep 2025 Issue date: 3 Oct 2019 |
Application | Utility: HETEROCYCLIC SPIRO COMPOUNDS AS MAGL INHIBITORS Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: NOVEL HETEROCYCLIC COMPOUNDS AS INHIBITORS OF VANIN-1 ENZYME Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: MEDIA AND FERMENTATION METHODS FOR PRODUCING POLYSACCHARIDES IN BACTERIAL CELL CULTURE Filling date: 13 Sep 2025 Issue date: 26 Sep 2019 |
Application | Utility: Cyclopentane-Based Modulators of STING (Stimulator of Interferon Genes) Filling date: 13 Sep 2025 Issue date: 19 Sep 2019 |
Application | Utility: 1,1,1-TRIFLUORO-3-HYDROXYPROPAN-2-YL CARBAMATE DERIVATIVES AS MAGL INHIBITORS Filling date: 13 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: Combination of an EGFR T790M Inhibitor and a CDK Inhibitor for the Treatment of Non-Small Cell Lung Cancer Filling date: 13 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: Cycloalkyl-Linked Diheterocycle Derivatives Filling date: 13 Sep 2025 Issue date: 5 Sep 2019 |
Showing 200 to 250 of 264 patents.